U.S. DNA-Based Diagnostic Test and Equipment Market Analysed in New ReportPiribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report analysing the DNA-based diagnostic test and equipment market in the U.S.
By: Jonna Dagliden “U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions: Market Trends, New Product Trends, Technology Trends, Distribution Structure and 15 Notable Company Case Studies” reports that DNA-based diagnostics are established in laboratory medicine with many of the top tests run for infectious disease. The report shows that the U.S. market for DNA-based infectious disease tests is today a $1.1 billion industry. Nucleic acid testing (NAT) is used to screen blood supplies; DNA-based tests are rapidly emerging as an oncology standard as well; and newer tests are more slowly developing as a way to treat other non-infectious diseases such as chronic diseases and diseases of ageing. However, they still operate largely outside of core medical practice today - which is the doctor's office and hospital lab. The study further examines the key players and issues in commercialising DNA-based diagnostics in the United States. It covers the market for testing products for infectious diseases, human cancers and pharmacogenomics, and the instrumentation needed to perform the tests. Furthermore, it analyses U.S. market structure and size by major product segments. It covers distribution structure; development trends and technology advances; regulations and policies for genetic privacy, insurance coverage and DNA counselling; “U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions: Market Trends, New Product Trends, Technology Trends, Distribution Structure and 15 Notable Company Case Studies” is available from Piribo. For more information go to: http://www.piribo.com/ Piribo product ID: FUJ00056 # # # About Piribo. Piribo (http://www.piribo.com/ End
|
|
Account Phone Number